Evidence map›Paper›PMID 40181214›Full record

ArticleAutophagy2025

Mitophagy-mediated S1P facilitates muscle adaptive responses to endurance exercise through SPHK1-S1PR1/S1PR2 in slow-twitch myofibers.

Minghong Leng, Fenghe Yang, Junhui Zhao, Yufei Xiong, Yiqing Zhou, Mingyang Zhao, Shi Jia, Limei Liu, Qiaoxia Zheng, Lebin Gan and 2 more

Abstract read
In one paragraph

Article in Autophagy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Minghong LengDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Fenghe YangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Junhui ZhaoDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Yufei XiongDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Yiqing ZhouDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Mingyang ZhaoDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Shi JiaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Limei LiuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Qiaoxia ZhengDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.
Lebin GanKey Laboratory of Trauma Treatment and Neural Regeneration (Peking University), National Center for Trauma Medicine, Trauma Medicine Center, Peking University People's Hospital, Beijing, P.R. China.
Jingjing YeKey Laboratory of Trauma Treatment and Neural Regeneration (Peking University), National Center for Trauma Medicine, Trauma Medicine Center, Peking University People's Hospital, Beijing, P.R. China.
Ming ZhengDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endurance exercise triggers adaptive responses especially in slow-twitch myofibers of skeletal muscles, leading to the remodeling of myofiber structure and the mitochondrial network. However, molecular mechanisms underlying these adaptive responses, with a focus on the fiber type-specific perspective, remains largely unknown. In this study we analyzed the alterations of transcriptomics and metabolomics in distinct skeletal myofibers in response to endurance exercise. We determined that genes associated with sphingolipid metabolism, namely those encoding SPHK1, S1PR1, and S1PR2, are enriched in slow-twitch but not fast-twitch myofibers from both mouse and human skeletal muscles, and found that the SPHK1-S1PR pathway is essential for adaptive responses of slow-twitch to endurance exercise. Importantly, we demonstrate that endurance exercise causes the accumulation of ceramides on stressed mitochondria, and the mitophagic degradation of ceramides results in an increase of the sphingosine-1-phosphate (S1P) level. The elevated S1P thereby facilitates mitochondrial adaptation and enhances endurance capacity via the SPHK1-S1PR1/S1PR2 axis in slow-twitch muscles. Moreover, administration of S1P improves endurance performance in muscle atrophy mice by emulating these adaptive responses. Our findings reveal that the SPHK1-S1P-S1PR1/S1PR2 axis through mitophagic degradation of ceramides in slow-twitch myofibers is the central mediator to endurance exercise and highlight a potential therapeutic target for ameliorating muscle atrophy diseases.

Indexed as

Adaptation, PhysiologicalLysophospholipidsMitophagyMuscle Fibers, Slow-TwitchPhosphotransferases (Alcohol Group Acceptor)Physical Conditioning, AnimalPhysical EnduranceSphingosineSphingosine-1-Phosphate ReceptorsAnimalsCeramidesHumansMaleMiceMice, Inbred C57BLMitochondriaCeramidesLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Sphingosinesphingosine 1-phosphateSphingosine-1-Phosphate ReceptorsSphingosine KinaseSphk1 protein, mouseEndurance exercisemitochondrial biogenesismitophagyskeletal musclesphingosine-1-phosphate

Identifiers

PMID40181214
PMCPMC12459366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.